0001352145-14-000002.txt : 20140515
0001352145-14-000002.hdr.sgml : 20140515
20140515142341
ACCESSION NUMBER: 0001352145-14-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140515
DATE AS OF CHANGE: 20140515
EFFECTIVENESS DATE: 20140515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sorbent Therapeutics Inc
CENTRAL INDEX KEY: 0001352145
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-217450
FILM NUMBER: 14846054
BUSINESS ADDRESS:
STREET 1: 710 LAKEWAY DRIVE
STREET 2: SUITE 290
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
BUSINESS PHONE: 408-857-5248
MAIL ADDRESS:
STREET 1: 710 LAKEWAY DRIVE
STREET 2: SUITE 290
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
D
1
primary_doc.xml
X0707
D
LIVE
0001352145
Sorbent Therapeutics Inc
710 LAKEWAY DRIVE
SUITE 290
SUNNYVALE
CA
CALIFORNIA
94085
408-738-8240
DELAWARE
None
None
Corporation
true
Detlef
Albrecht
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Director
David
Collier
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Director
James
Healy
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Director
Donald
Joseph
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Director
Scott
Minick
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Director
Marcus
Goebel
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Director
Randall
Woods
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Director
Howard
C.
Dittrich
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Linda
De Young
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Thomas
P.
O'Neil
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Jason
Levin
710 Lakeway Drive,
Suite 290
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2014-04-30
false
true
false
0
15000000
6500000
8500000
false
10
0
0
0
false
Sorbent Therapeutics Inc
/s/ Thomas P. O'Neil
Thomas P. O'Neil
Chief Financial Officer
2014-05-13